These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
413 related items for PubMed ID: 18045552
1. Protective role of calreticulin in HFE hemochromatosis. Pinto JP, Ramos P, de Almeida SF, Oliveira S, Breda L, Michalak M, Porto G, Rivella S, de Sousa M. Free Radic Biol Med; 2008 Jan 01; 44(1):99-108. PubMed ID: 18045552 [Abstract] [Full Text] [Related]
2. Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice. Delima RD, Chua AC, Tirnitz-Parker JE, Gan EK, Croft KD, Graham RM, Olynyk JK, Trinder D. Hepatology; 2012 Aug 01; 56(2):585-93. PubMed ID: 22383097 [Abstract] [Full Text] [Related]
3. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis]. Loréal O, Ropert M, Mosser A, Déhais V, Deugnier Y, David V, Brissot P, Jouanolle AM. Presse Med; 2007 Sep 01; 36(9 Pt 2):1271-7. PubMed ID: 17521857 [Abstract] [Full Text] [Related]
4. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Gao J, Chen J, Kramer M, Tsukamoto H, Zhang AS, Enns CA. Cell Metab; 2009 Mar 01; 9(3):217-27. PubMed ID: 19254567 [Abstract] [Full Text] [Related]
5. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, Kahn A, Andrews NC, Vaulont S. Nat Genet; 2003 May 01; 34(1):97-101. PubMed ID: 12704388 [Abstract] [Full Text] [Related]
6. Non-HFE hemochromatosis. Pietrangelo A. Semin Liver Dis; 2005 Nov 01; 25(4):450-60. PubMed ID: 16315138 [Abstract] [Full Text] [Related]
7. Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin. Herrmann T, Muckenthaler M, van der Hoeven F, Brennan K, Gehrke SG, Hubert N, Sergi C, Gröne HJ, Kaiser I, Gosch I, Volkmann M, Riedel HD, Hentze MW, Stewart AF, Stremmel W. J Mol Med (Berl); 2004 Jan 01; 82(1):39-48. PubMed ID: 14618243 [Abstract] [Full Text] [Related]
8. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis. Gleeson F, Ryan E, Barrett S, Russell J, Crowe J. Blood Cells Mol Dis; 2007 Jan 01; 38(1):37-44. PubMed ID: 17098454 [Abstract] [Full Text] [Related]
12. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Biasiotto G, Belloli S, Ruggeri G, Zanella I, Gerardi G, Corrado M, Gobbi E, Albertini A, Arosio P. Clin Chem; 2003 Dec 01; 49(12):1981-8. PubMed ID: 14633868 [Abstract] [Full Text] [Related]
14. Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis. Sangwaiya A, Manglam V, Busbridge M, Thursz M, Arnold J. Eur J Gastroenterol Hepatol; 2011 Aug 01; 23(8):721-4. PubMed ID: 21654321 [Abstract] [Full Text] [Related]
17. Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene. Altès A, Bach V, Ruiz A, Esteve A, Felez J, Remacha AF, Sardà MP, Baiget M. Ann Hematol; 2009 Oct 01; 88(10):951-5. PubMed ID: 19214511 [Abstract] [Full Text] [Related]